The state government has issued an order to start the “post-COVID mucormycosis management” procedure under Aarogyasri, which is an epidemic disease due to the increasing number of cases in patients who have recovered from COVID with uncontrolled diabetes, prolonged use of high-dose steroids and immunosuppressants .
According to the GO, the new procedure for the disease includes a 14-day stay for the patient in the hospital, where the disease is diagnosed and treated. According to the treatment protocol, patients are given intravenous antibiotics, intravenous fluids, liposomal amphotericin B, or oral posaconazole for two to three weeks based on the clinical evaluation.
Meanwhile, Chief Secretary for Health, Medicine and Family Welfare, Anil Kumar Singhal, said the state had ordered over 15,000 vials of drugs for the treatment of mucormycosis from three companies in addition to the 1,650 allocated by the center.
In a press conference on Wednesday, he said treatment for mucormycosis would cost up to £ 3 per person and the government had included the disease in the Aarogyasri program.
He said information on black fungus was still being collected. The health department has notified 17 government and teaching hospitals across the state of treatment for the disease.